Jie Lv

Putuo People's Hospital, Tongji University

Affiliated withTongji University

Research Area

Biography

Jie Lv has not added Biography.
If you are Jie Lv and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 2	2022

Other Publications

Article	Year
Antiasthmatic drugs targeting the cysteinyl leukotriene receptor 1 alleviate central nervous system inflammatory cell infiltration and pathogenesis of experimental autoimmune encephalomyelit... Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 21804021	2011
The antiepileptic drug valproic acid restores T cell homeostasis and ameliorates pathogenesis of experimental autoimmune encephalomyelitis. The Journal of biological chemistry\| PubMed ID: 22733814	2012
Blocking A2B adenosine receptor alleviates pathogenesis of experimental autoimmune encephalomyelitis via inhibition of IL-6 production and Th17 differentiation. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 23225885	2013
Discovery of Xuebijing Injection Exhibiting Protective Efficacy on Sepsis by Inhibiting the Expression of HMGB1 in Septic Rat Model Designed by Cecal Ligation and Puncture. American journal of therapeutics\| PubMed ID: 26313171	2016
Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination. Nature communications\| PubMed ID: 27040771	2016
Activation of A and A adenosine receptors promotes neural progenitor cell proliferation. Brain research\| PubMed ID: 29476752	2018
The novel small-molecule TPN10456 inhibits Th17 cell differentiation and protects against experimental autoimmune encephalomyelitis. Cellular & molecular immunology\| PubMed ID: 33110252	2020
MiniCAFE, a CRISPR/Cas9-based compact and potent transcriptional activator, elicits gene expression in vivo. Nucleic acids research\| PubMed ID: 33751124	2021
9,10-Anhydrodehydroartemisinin Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Th1 and Th17 Cell Differentiation. Inflammation\| PubMed ID: 33788130	2021
Erratum for article 'MiniCAFE, a CRISPR/Cas9-based compact and potent transcriptional activator, elicits gene expression invivo'. Nucleic acids research\| PubMed ID: 34009338	2021
Methyl Butyrate Alleviates Experimental Autoimmune Encephalomyelitis and Regulates the Balance of Effector T Cells and Regulatory T Cells. Inflammation\| PubMed ID: 34786625	2022
Methyl acetate arrests Th1 in peripheral immune system and alleviates CNS inflammation in EAE. International immunopharmacology\| PubMed ID: 34799286	2021
Artemisinin derivative TPN10466 suppresses immune cell migration and Th1/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis. Cellular immunology\| PubMed ID: 35276582	2022
Chlorzoxazone Alleviates Experimental Autoimmune Encephalomyelitis via Inhibiting IL-6 Secretion of Dendritic Cells. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 35277421	2022
Synthesis and biological evaluation of artemisinin derivatives as potential MS agents. Bioorganic & medicinal chemistry letters\| PubMed ID: 35304225	2022
Amelioration of Experimental Autoimmune Encephalomyelitis in Alzheimer's Disease Mouse Models: A Potential Role for Aβ. Cells\| PubMed ID: 35326455	2022